The landscape of dementia prognosis has developed considerably with the arrival of innovative biomarkers, which include amyloid PET scans, tau imaging, and blood-based mostly exams that may detect Alzheimer's pathology years ahead of signs or symptoms emerge. While these technological innovations characterize impressive progress in being familiar with neurodegenerative disorders, https://theoj429kue0.bloggazza.com/profile